Somatic hypermutation targeting is influenced by location within the immunoglobulin V region

Molecular Immunology

Volumn 48, Issue 12-13, 2011, Pages 1477-1483

  Cohen, Reuma Magori ^a   Kleinstein, Steven H ^b,c   Louzoun, Yoram ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b YALE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AID; B cells; Germinal centers; Hypermutation; Immunoglobulin; Selection

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; B LYMPHOCYTE; CODON; GENE TARGETING; IMMUNOGENETICS; IMMUNOGLOBULIN VARIABLE REGION; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; STATISTICAL ANALYSIS;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MODELS, GENETIC; MODELS, STATISTICAL; MUTATION; SEQUENCE ANALYSIS, DNA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 79957835550     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.04.002     Document Type: Article

References (37)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Anderson S.M., Khalil A., Uduman M., Hershberg U., Louzoun Y., Haberman A.M., Kleinstein S.H., Shlomchik M.J. Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells. J. Immunol. 2009, 183:7314-7325.
3. Betz A.G., Rada C., Pannell R., Milstein C., Neuberger M.S. Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:2385-2388.
4. Celada F., Seiden P.E. Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur. J. Immunol. 1996, 26:1350-1358.
5. Chezar I., Lobel-Lavi L., Steinitz M., Laskov R. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line. Mol. Immunol. 2008, 46:80-90.
6. Delbos F., Aoufouchi S., Faili A., Weill J.C., Reynaud C.A. DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 2007, 204:17-23.
7. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 2007, 76:1-22.
8. Griffiths G.M., Berek C., Kaartinen M., Milstein C. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature 1984, 312:271-275.
9. Kabat E.A., Wu T.T. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J. Immunol. 1991, 147:1709-1719.
10. Kepler T.B. Codon bias and plasticity in immunoglobulins. Mol. Biol. Evol. 1997, 14:637-643.
11. Kleinstein S.H., Louzoun Y., Shlomchik M.J. Estimating hypermutation rates from clonal tree data. J. Immunol. 2003, 171:4639-4649.
12. Larijani M., Frieder D., Sonbuchner T.M., Bransteitter R., Goodman M.F., Bouhassira E.E., Scharff M.D., Martin A. Methylation protects cytidines from AID-mediated deamination. Mol. Immunol. 2005, 42:599-604.
13. Lefranc M.P. IMGT, The international ImMunoGeneTics information system. Methods Mol. Biol. 2004, 248:27-49. http://imgt.cines.fr/.
14. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
15. MacCarthy T., Kalis S.L., Roa S., Pham P., Goodman M.F., Scharff M.D., Bergman A. V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8629-8634.
16. MacLennan I.C. Germinal centers still hold secrets. Immunity 2005, 22:656-657.
17. Maizels N. Immunoglobulin gene diversification. Annu. Rev. Genet. 2005, 39:23-46.
18. Melamed D., Benschop R.J., Cambier J.C., Nemazee D. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 1998, 92:173-182.
19. Milstein C., Neuberger M.S., Staden R. Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8791-8794.
20. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
21. Odegard V.H., Schatz D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 2006, 6:573-583.
22. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., Scharff M.D. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 2008, 26:481-511.
23. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., Redon C., Ried T., Bonner W.M., Honjo T., Nussenzweig M.C., Nussenzweig A. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001, 414:660-665.
24. Pham P., Bransteitter R., Petruska J., Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003, 424:103-107.
25. Prak E.L., Weigert M. Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med. 1995, 182:541-548.
26. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., Kayserili H., Ugazio A.G., Brousse N., Muramatsu M., Notarangelo L.D., Kinoshita K., Honjo T., Fischer A., Durandy A. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
27. Rogozin I.B., Diaz M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 2004, 172:3382-3384.
28. Rogozin I.B., Kolchanov N.A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1992, 1171:11-18.
29. Rogozin I.B., Pavlov Y.I., Bebenek K., Matsuda T., Kunkel T.A. Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat. Immunol. 2001, 2:530-536.
30. Shapiro G.S., Wysocki L.J. DNA target motifs of somatic mutagenesis in antibody genes. Crit. Rev. Immunol. 2002, 22:183-200.
31. Shlomchik M.J., Litwin S., Weigert M. The influence of somatic mutation on clonal expansion. Prog. Immunol. 1990, VII:415.
32. Smith D.S., Creadon G., Jena P.K., Portanova J.P., Kotzin B.L., Wysocki L.J. Di- and trinucleotide target preferences of somatic mutagenesis in normal and autoreactive B cells. J. Immunol. 1996, 156:2642-2652.
33. Wilson T.M., Vaisman A., Martomo S.A., Sullivan P., Lan L., Hanaoka F., Yasui A., Woodgate R., Gearhart P.J. MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J. Exp. Med. 2005, 201:637-645.
34. Yu K., Huang F.T., Lieber M.R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 2004, 279:6496-6500.
35. Zeng X., Winter D.B., Kasmer C., Kraemer K.H., Lehmann A.R., Gearhart P.J. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2001, 2:537-541.
36. Zheng N.Y., Wilson K., Jared M., Wilson P.C. Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J. Exp. Med. 2005, 201:1467-1478.
37. Zuckerman N.S., Hazanov H., Barak M., Edelman H., Hess S., Shcolnik H., Dunn-Walters D., Mehr R. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J. Autoimmun. 2010, 35:325-335.